Defence of The ClonesNew Clinical Trial Will Use Artificial Antibodies to Treat Covid19 Lung Inflammation Gimsilumab, an artificially synthesized antibody, could significantly reduce Covid19-related lung injuries. By Devrupa Rakshit
